To identify the genes encoding the tumor antigens recognized by CD4+ tumor-specific T cells, we used a genetic targeting expression system, which has been used to identify several MHC class II-restricted tumor antigens [20,22,26]. This evidence concerns the gene CD4 and neoplasm.